Bone Biologics Corp (BBLG)

Currency in USD
0.5050
+0.0201(+4.15%)
Real-time Data·
BBLG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.46030.5497
52 wk Range
0.42802.8900
Key Statistics
Prev. Close
0.4849
Open
0.47
Day's Range
0.4603-0.5497
52 wk Range
0.428-2.89
Volume
398.68K
Average Volume (3m)
375.05K
1-Year Change
-76.2911%
Book Value / Share
2.19
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BBLG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Bone Biologics Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Earnings

Latest Release
Sep 02, 2026
EPS / Forecast
-0.43 / -0.39
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BBLG Income Statement

Compare BBLG to Peers and Sector

Metrics to compare
BBLG
Peers
Sector
Relationship
P/E Ratio
−0.5x−2.2x−0.4x
PEG Ratio
0.000.070.00
Price/Book
0.4x2.5x2.6x
Price / LTM Sales
-4.9x3.1x
Upside (Analyst Target)
-264.5%52.9%
Fair Value Upside
Unlock7.4%6.4%Unlock

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
8.47K0.31%4.03K
Other Institutional Investors
138.06K5.01%65.68K
Public Companies & Retail Investors
2.61M94.68%1.24M
Total
2.76M100.00%1.31M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Armistice Capital LLC4.06%112,00053
Citadel Advisors LLC0.87%23,87911

People Also Watch

0.02
SNYRQ
-10.61%
2.42
RBNE
+2.75%
0.239
VNRX
-9.38%
2.0500
GCTK
-7.66%
1.1099
CISS
-2.64%

FAQ

What Is the Bone Biologics (BBLG) Stock Price Today?

The Bone Biologics stock price today is 0.5050 USD.

What Stock Exchange Does Bone Biologics Trade On?

Bone Biologics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Bone Biologics?

The stock symbol for Bone Biologics is "BBLG."

What Is the Bone Biologics Market Cap?

As of today, Bone Biologics market cap is 1.3900M USD.

What Is Bone Biologics's Earnings Per Share (TTM)?

The Bone Biologics EPS (TTM) is -1.6055.

When Is the Next Bone Biologics Earnings Date?

Bone Biologics will release its next earnings report on Dec 02, 2026.

From a Technical Analysis Perspective, Is BBLG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bone Biologics Stock Split?

Bone Biologics has split 5 times.

How Many Employees Does Bone Biologics Have?

Bone Biologics has 2 employees.

What is the current trading status of Bone Biologics (BBLG)?

As of Sep 23, 2026, Bone Biologics (BBLG) is trading at a price of 0.5050 USD, with a previous close of 0.4849 USD. The stock has fluctuated within a day range of 0.4603 USD to 0.5497 USD, while its 52-week range spans from 0.4280 USD to 2.8900 USD.

What Is Bone Biologics (BBLG) Price Target According to Analysts?

The average 12-month price target for Bone Biologics is 12.2000 USD, with a high estimate of 12.2 USD and a low estimate of 12.2 USD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +2,315.84% Upside potential.

What Is the BBLG Premarket Price?

BBLG's last pre-market stock price is 0.4603 USD. The pre-market share volume is 1,650.0000, and the stock has decreased by -0.0246, or -5.0700%.

What Is the BBLG After Hours Price?

BBLG's last after hours stock price is 0.4920 USD, the stock has decreased by 0.0071, or 1.4600%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.